Sort
23,748 grants matching “melanoma”
Molecular basis of melanocytic nevi
$167,940Maija Helena Tuulia Kiuru · University Of California At Davis · K23 · FY2022 · AR
Molecular basis of melanocytic nevi
$167,940Maija Helena Tuulia Kiuru · University Of California At Davis · K23 · FY2023 · AR
A novel cellular tumor vaccine strategy for mutant IDH1 glioma
$167,921Michael D Gunn · Duke University · P50 · FY2021 · CA
Exploiting the Unique T Cell Response to CMV for a Cancer Vaccine
$167,845Ann B Hill · Oregon Health & Science University · R21 · FY2010 · CA
Activation of pDCs in Murine Tumor Models
$167,833Willem W Overwijk · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
$167,791Scott J Antonia · H. Lee Moffitt Cancer Ctr & Res Inst · K24 · FY2010 · CA
MATCHMAKERS
$167,757Ton Schumacher · Netherlands Cancer Institute · OT2 · FY2024 · CA
Core D: Animal Experimentation & Wound Healing
$167,746Kevin D Cooper · Case Western Reserve University · P30 · FY2015 · AR
Quantification of the environmental UVA exposure
$167,631Michael G Kimlin · Queensland University Of Technology · R01 · FY2008 · CA
Quantification of the environmental UVA exposure
$167,631Michael G Kimlin · Queensland University Of Technology · R01 · FY2007 · CA
NAC for melanoma chemoprevention
$167,619Douglas Grossman · University Of Utah · R21 · FY2010 · AR
Immunogene Therapy of Mesothelin Expressing Tumors Using Engineered T Cells
$167,527Carl H. June · University Of Pennsylvania · P01 · FY2015 · CA
Immunogene Therapy of Mesothelin Expressing Tumors Using Engineered T Cells
$167,527Carl H. June · University Of Pennsylvania · P01 · FY2016 · CA
Systems analysis of phenotypic switch in control of cancer invasion
$167,500Andre Levchenko · Yale University · U54 · FY2016 · CA
Genetically Modified Natural Killer Cells for Cancer Immunotherapy
$167,476Branden S Moriarity · University Of Minnesota · R21 · FY2018 · CA
Diagnosing Emergence of Kinase Inhibitor Resistance on a Microchip
$167,475Thomas G Graeber · University Of California Los Angeles · R21 · FY2012 · CA
Hereditary cancer predisposition syndromes and uveal melanoma
$167,475Mohamed H. Abdel-Rahman · Ohio State University · R21 · FY2016 · CA
Targeting melanoma hypoxia with lactic acid bacterium L. lactis
$167,475Jorge G Gomez-Gutierrez · University Of Louisville · R21 · FY2018 · CA
Post-transplant Cutaneous Squamous Cell Carcinoma and Macrophage Migration Inhibitory Factor
$167,475Tatiana M Oberyszyn · Ohio State University · R21 · FY2017 · CA
IL-27-based cancer vaccination approach for cancer immunotherapy
$167,475Xue-Feng Bai · Ohio State University · R21 · FY2015 · CA
Role of senescent fibroblasts in UVB-induced carcinogenesis
$167,475Dan F Spandau · Indiana University Indianapolis · R21 · FY2010 · CA
T cell responses shared among triple negative breast cancer patients
$167,411Jill E Slansky · University Of Colorado Denver · R21 · FY2019 · CA
Admin. Suppl. for NCI CCSG/Moonshot Grant to Develop Immune Radiation Response Index (iRRI) for Immune Cells from Normal and Tumor Microenvironments
$167,344Raphael E. Pollock · Ohio State University · P30 · FY2022 · CA
Targeting Lipid Metabolism in the Tumor Microenvironment
$167,328Ashani T Weeraratna · Wistar Institute · P01 · FY2023 · CA
Specimen Resource Core
$167,269Ruth Halaban · Yale University · P50 · FY2012 · CA